Terpene Derivative Anti-Inflammatory Composition with Reduced Side Effects

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current anti-inflammatory agents are often ineffective for certain inflammatory conditions and can have adverse side effects, making them unsuitable for all patients, particularly pregnant individuals or those with inflammatory bowel disease.

Innovation Solution

A composition containing a compound of formula (I) or its pharmaceutically acceptable derivative is administered in a weight percentage of at least 1% to treat or prevent inflammation, reducing symptoms and addressing inflammatory disorders without the common side effects of existing agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current anti-inflammatory agents (steroids and NSAIDs) are used to treat inflammation, then inflammatory symptoms are reduced, but adverse side effects occur including gastrointestinal damage, renal damage, and other systemic effects

Engineering Contradiction:
Improveanti-inflammatory efficacyVSAvoidadverse side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies parameter changes by modifying the chemical structure of natural terpene compounds through specific derivatization reactions to create compounds with enhanced anti-inflammatory activity and reduced side effects. The structural modifications alter the pharmacological parameters of the parent compounds to achieve better therapeutic profiles

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials by combining terpene core structures with various functional groups and moieties to create hybrid compounds that exhibit synergistic effects. These composite molecular structures integrate the benefits of different chemical features to achieve potent anti-inflammatory activity with improved safety profiles

Inventive Principle:
Principle #40Composite materials

2Reliability

If current anti-inflammatory agents are used, then inflammation is treated, but the drugs are ineffective for certain inflammatory conditions or subject populations

Engineering Contradiction:
Improveanti-inflammatory efficacyVSAvoidsuitability for different subjects and conditions
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent utilizes parameter changes by systematically varying chemical parameters of terpene derivatives to optimize activity across different inflammatory conditions and subject populations. This includes adjusting functional groups, molecular weight, and lipophilicity to achieve broad-spectrum efficacy and improved suitability for pregnant subjects and those with inflammatory bowel disease

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent achieves universality by developing terpene derivative compounds that demonstrate multi-functional anti-inflammatory activity applicable to various inflammatory conditions. The compounds show efficacy across different inflammatory pathways and are suitable for diverse subject populations including pregnant women and patients with inflammatory bowel disease

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compound effectively inhibits TNF-α and has limited COX-2 inhibitory activity, providing therapeutic benefits for inflammation and pain management with reduced adverse effects.

Implementation Method 1

The compound effectively inhibits TNF-α and has limited COX-2 inhibitory activity, providing therapeutic benefits for inflammation and pain management with reduced adverse effects

Methodology Applied
Scientific EffectTNF-α inhibition:

Data Source

PatentUS11759448B2Methods for the treatment of inflammation
Publication Date: 2023.09.19 SPRAINGO LLC
  • US11759448B2 patent drawing
  • US11759448B2 patent drawing
  • US11759448B2 patent drawing

AI summary

The present disclosure is directed to methods for the treatment of inflammation or pain, particularly methods using compositions containing a compound of formula (I).